SCHEMBL3321037

SCHEMBL3321037

Cc1c(CN2CCN(c3nccnc3-c3cccc(C(F)(F)F)c3)CC2)cnn1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 1/20 0.53
KDM4E B2RXH2 6/20 0.44
MAPT P10636 2/20 0.44
DHFR P00374 1/20 0.43
HTR7 P34969 1/20 0.43
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
POLB P06746 1/20 0.41
CNR2 P34972 2/20 0.40
GRM2 Q14416 2/20 0.40
CNR1 P21554 1/20 0.40
PKM P14618 1/20 0.40
ALPI P09923 1/20 0.40
ALPG P10696 1/20 0.40
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
XBP1 P17861 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9961725 0.89 SMO (0.52) SMOKDM4EMAPTDHFRHTR7
SCHEMBL9961637 0.88 TDP1 (0.46) SMOKDM4EMAPTHTR7ALDH1A1
Hydrochloric Acid SCHEMBL3321845 0.88 SMO (0.51) SMOKDM4EMAPTDHFRHTR7
SCHEMBL9961736 0.87 ALDH1A1 (0.46) SMOKDM4EMAPTALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL3317914 0.87 TDP1 (0.46) SMOKDM4EMAPTHTR7ALDH1A1
Hydrochloric Acid SCHEMBL3326678 0.86 ALDH1A1 (0.45) SMOKDM4EMAPTALDH1A1L3MBTL1
SCHEMBL9961739 0.85 SMO (0.50) SMOKDM4EHTR7ALDH1A1L3MBTL1
SCHEMBL9961685 0.84 SIGMAR1 (0.41) SMOKDM4EALDH1A1L3MBTL1CNR2
Hydrochloric Acid SCHEMBL3321135 0.84 SMO (0.49) SMOKDM4EHTR7ALDH1A1L3MBTL1
SCHEMBL9961733 0.83 HSD11B1 (0.47) SMOKDM4EALDH1A1POLBCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155717-B1 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2012-10-24 EP disclosed
US-8202873-B2 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists ELI LILLY AND COMPANY (US) 2012-06-19 US disclosed
US-20100120785-A1 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2010-05-13 US disclosed
EP-2155717-A1 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2010-02-24 EP disclosed
WO-2008141020-A1 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2008-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120785-A1 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS HTR7, HTR2C, HTR4 SMO 1103/4885KDM4E 1816/4885MAPT 2476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.